Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Diabetes
•
Endocrinology
Do patients with advanced chronic kidney disease tend to have falsely high HbA1c or falsely low HbA1c levels?
https://doi.org/10.2337/dc22-1399
Related Questions
Should we be using body fat percentage instead of BMI for determining patients' risk of metabolic syndrome?
Can a patient with a PMHx of pancreatic injury or disease (i.e. blunt trauma, recurrent pancreatitis) take a GLP-1 agonist safely in the setting of morbid obesity and type 2 diabetes?
When managing patients with suspected MASLD, what specific criteria or findings would prompt you to refer them to hepatology?
Which screening method for diabetes do you consider to be the most sensitive?
Do you recommend the use of GLP1 R agonist therapy in patients with T1DM for weight loss?
What is the therapeutic role and blood glucose lowering capability of Bromocriptine and Cholestyramine for the treatment of Type 2 diabetes?
Are recurrent UTIs a contraindication to SGLT2i use?
Do you use the homeostatic model assessment (HOMA) to assess for insulin resistance and change your clinical management of patients?
Should we recommend SGLT2i initiation at discharge to all patients hospitalized with acute myocardial infarction?
Which patients would benefit most from teplizumab therapy to delay the onset of T1DM?
